NIH scientists, Drs. Harry M. Meyer, Jr. and Paul D. Parkman, developers of a promising new experimental vaccine against rubella (German measles). Here, they inspect a culture of the virus used in preparing the vaccine. [caption on verso:] Rubella is a major hazard to unborn infants whose mothers may have become infected during pregnancy. Deformity, blindness, deafness, heart disease and mental retardation are possible consequences of pre-birth rubella infection. The Meyer-Parkman vaccine is now undergoing further development and testing prior to large scale commercial production for general use.
The National Library of Medicine believes this item to be in the public domain. (More information)